Agreed on cooperation but much more influence on FDA by big pharma. FDA looks ready to move affirmatively when Flaskworks is ready. If FDA and MHRA are cooperating it may have even been suggested that NWBO start in the UK because of uncertainty about commercial launch readiness in the US because of the larger market and to prevent any push back from big pharma on their members. UK validation would make it nearly impossible for big pharma influence to interfere with “the process”. Best wishes.
Market Data 
Markets 
AI
